CDK6 levels regulate quiescence exit in human hematopoietic stem cells.

Area of Science:

• Hematology
• Stem Cell Biology
• Molecular Biology

Background:

• Regulated blood production relies on a hierarchy of hematopoietic stem cell (HSC) subsets with varying self-renewal and division rates.
• Long-term (LT)-HSCs divide infrequently, but the molecular basis for this difference in division kinetics remains unclear.

Purpose of the Study:

• To investigate the molecular mechanisms controlling differential division kinetics among human HSC subsets.
• To determine the role of CDK6 in regulating HSC quiescence and cell cycle entry.

Main Methods:

• Analysis of CDK6 protein expression in distinct human HSC subsets (LT-HSCs and ST-HSCs).
• Functional assays involving enforced CDK6 expression in LT-HSCs.
• Computational modeling to simulate HSC division kinetics and pool preservation.

Main Results:

• LT-HSCs were found to lack CDK6 protein, while short-term (ST)-HSCs exhibited high CDK6 levels.
• Enforced CDK6 expression in LT-HSCs accelerated quiescence exit and provided a competitive advantage without altering HSC function.
• Computational models supported the hypothesis that differential CDK6 expression independently controls quiescence exit kinetics, limiting LT-HSC divisions.

Conclusions:

• Differential CDK6 expression is a key mechanism regulating heterogeneity in HSC quiescence states.
• This regulation of quiescence exit kinetics by CDK6 is crucial for preserving the HSC pool and ensuring lifelong hematopoiesis.